1. Home
  2. TMCI vs HPS Comparison

TMCI vs HPS Comparison

Compare TMCI & HPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMCI
  • HPS
  • Stock Information
  • Founded
  • TMCI 2014
  • HPS 2003
  • Country
  • TMCI United States
  • HPS United States
  • Employees
  • TMCI N/A
  • HPS N/A
  • Industry
  • TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • HPS Investment Managers
  • Sector
  • TMCI Health Care
  • HPS Finance
  • Exchange
  • TMCI Nasdaq
  • HPS Nasdaq
  • Market Cap
  • TMCI 516.6M
  • HPS 476.4M
  • IPO Year
  • TMCI 2021
  • HPS N/A
  • Fundamental
  • Price
  • TMCI $8.45
  • HPS $15.06
  • Analyst Decision
  • TMCI Hold
  • HPS
  • Analyst Count
  • TMCI 8
  • HPS 0
  • Target Price
  • TMCI $9.00
  • HPS N/A
  • AVG Volume (30 Days)
  • TMCI 418.1K
  • HPS 58.4K
  • Earning Date
  • TMCI 05-06-2025
  • HPS 01-01-0001
  • Dividend Yield
  • TMCI N/A
  • HPS 8.62%
  • EPS Growth
  • TMCI N/A
  • HPS N/A
  • EPS
  • TMCI N/A
  • HPS N/A
  • Revenue
  • TMCI $209,357,000.00
  • HPS N/A
  • Revenue This Year
  • TMCI $10.86
  • HPS N/A
  • Revenue Next Year
  • TMCI $10.06
  • HPS N/A
  • P/E Ratio
  • TMCI N/A
  • HPS N/A
  • Revenue Growth
  • TMCI 11.88
  • HPS N/A
  • 52 Week Low
  • TMCI $3.92
  • HPS $11.79
  • 52 Week High
  • TMCI $13.24
  • HPS $15.40
  • Technical
  • Relative Strength Index (RSI)
  • TMCI 46.15
  • HPS 48.03
  • Support Level
  • TMCI $8.34
  • HPS $15.00
  • Resistance Level
  • TMCI $8.87
  • HPS $15.32
  • Average True Range (ATR)
  • TMCI 0.41
  • HPS 0.14
  • MACD
  • TMCI 0.05
  • HPS 0.01
  • Stochastic Oscillator
  • TMCI 62.50
  • HPS 57.26

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

About HPS John Hancock Preferred Income Fund III Preferred Income Fund III

John Hancock Preferred Income Fund III is a closed-end, diversified management investment company. Its investment objective is to provide a high level of current income consistent with preservation of capital. The fund's secondary investment objective is to provide growth of capital to the extent consistent with its primary investment objective. It seeks to achieve the objectives by investing a majority of its assets in preferred stocks and other preferred securities, including convertible preferred securities. The portfolio composition of the company consists of the U.S. preferred securities, foreign preferred securities, common stocks, corporate bonds, and the short-term investments.

Share on Social Networks: